## **Trustees’ Annual Report for the period** **From 01.01.2023 Period start date To 31.12.2023 Period end date Charity name: UK Acute Oncology Society** ## **Charity registration number: 1199351** ## **Objectives and Activities** ||SORP reference|| |---|---|---| |Summary of the purposes of
the charity as set out in its
governing document|Para 1.17|•For the public benefit, to advance the
education of all healthcare professionals
involved in treating or supporting patients
in the field of acute oncology.
•In furtherance of the object above, to
promote research for the public benefit in
all aspects of that subject and to publish
the useful results.
•The relief of sickness and preservation of
health, from cancer, among people
residing permanently or temporarily in the
UK.
•To assist in the treatment and care of
persons suffering from cancer, or in need
of rehabilitation, by the provision of
education for healthcare professionals.
•To promote the wellbeing of people
suffering from acute effects of cancer
and/or anti-cancer treatment and support
the development of acute oncology
services in the UK through assisting in
the provision of education.| |Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.|Para 1.17 and
1.19|1. Provision of forum for Health Care
professionals
supporting
emergency
cancer care.
2. Annual educational programme.
3. Website and educational resources.
4. Supporting service innovation, shared
learning and research promotion.| |Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit|Para 1.18|The UKAOS trustees have had regard to the
guidance issued by the Charity Commission
on public benefit.| **Additional information (optional)** You may choose to include further statements where relevant about: SORP reference Para 1.38 Policy on grant making Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other ## **Achievements and Performance** ||SORP reference|| |---|---|---| |Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.|Para 1.20|**Governance**
•Successful transition to a new
Secretariat (media1) June 2023
•First UKAOS Annual General
Meeting held 06/12/23
•Maintained
quarterly
Board
meetings with c1100 UKAOS
members, at the year end.
**Educational outputs**
•Jan 2023: ½ day workshop
hosted at Liverpool Royal College
of Physicians (RCP) offices -with
RCP/Macmillan
and
UKAOS
focussed
on
emergency
presentation as a transition point
in
the
cancer
journey.
The
workshop
outputs
have
underpinned
a
joint
national
initiative
to
improve
communication
around
future
care planning.
•16/06/23: UKAOS session at UK
Oncology
Forum
(UKOF23)
national Cancer conference| |•10/11/23: Joint 1 day conference| |---| |with
UKAOS/Association
of| |Cancer Physicians (ACP) Leeds| |Acute Oncology Initial management| |guidelines (V4) published Feb 2023| |Society of Acute Medicine (SAMBA22)| |audit publication: Clinical Medicine 2023| |Vol 23, No 6: 1–11| |Acute care toolkit 7: Acute oncology on| |the acute medical unit November 2023.| |The acute care toolkit series can be| |accessed online atwww.rcp.ac.uk/act| ## **Additional information (optional)** You may choose to include further statements where relevant about: |Achievements against
objectives set|Para 1.41|| |---|---|---| |Performance of fundraising
activities against objectives
set|Para 1.41|| |Investment performance
against objectives|Para 1.41|| |Other||| ## **Financial Review** |**Financial Review**||| |---|---|---| |Review of the charity’s
financial position at the end
of the period|Para 1.21|Details of receipts and payments are given
in the Receipts and Payments Account
within the financial statements. The total
unrestricted funds as at 31 December 2023
amounted to £20,074 (2022: £4,494)| |Statement explaining the
policy for holding reserves
stating why they are held|Para 1.22|To fund future projects.| |Amount of reserves held|Para 1.22|The free reserves at 31 December 2023 are
£14,074 (2022: £4,494) and the trustees are
satisfied that this level of reserves is| |||sufficient to meet the needs of the charity in
its early stages of development.| |---|---|---| |Reasons for holding zero
reserves|Para 1.22|Not applicable.| |Details of fund materially in
deficit|Para 1.24|None.| |Explanation of any
uncertainties about the
charity continuing as a going
concern|Para 1.23|There are no uncertainties about the charity
continuing as a going concern.| ## **Additional information (optional)** You may choose to include further statements where relevant about: |||| |---|---|---| |The charity’s principal
sources of funds (including
any fundraising)|Para 1.47|| |Investment policy and
objectives including any
social investment policy
adopted|Para 1.46|| |A description of the principal
risks facing the charity|Para 1.46|| |Other||| ## **Structure, Governance and Management** |Description of charity’s
trusts:||| |---|---|---| |Type of governing document
(trust deed, royal charter)|
Para 1.25|Constitution.| |How is the charity
constituted?
(e.g unincorporated
association, CIO)|Para 1.25|Charitable Incorporated Organisation (CIO)| |Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees|Para 1.25|Election by UKAOS members at Annual
General Meeting.| **Additional information (optional)** You may choose to include further statements where relevant about: |Policies and procedures
adopted for the induction
and training of trustees|Para 1.51|| |---|---|---| |The charity’s organisational
structure and any wider
network with which the
charity works|Para 1.51|| |Relationship with any related
parties|Para 1.51|| |Other||| ## **Reference and Administrative details** |Charity name|UK Acute Oncology Society| |---|---| |Other name the charity uses|UKAOS| |Registered charity number|1199351| |Charity’s principal address|UKAOS Secretariat
c/o Media1 Productions Ltd
Clarence Mill, Clarence Road
Bollington
Macclesfield
SK10 5JZ| ||| ## **Names of the charity trustees who manage the charity** |1
2
3
4
5
6
7
8
9
10
11
12
13
14
15|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**
**year **|**Name of person (or body) entitled**
**to appoint trustee (ifany)**| |---|---|---|---|---| ||Dr E Marshall|Chair||| ||Dr C Mitchell|||| ||Dr H J Williams|Treasurer||| ||P J Jones|||| ||N R Clatworthy|||| ||Dr C Wilson|||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| 16 17 18 19 20 ## – Corporate trustees names of the directors at the date the report was approved ## **Director name** Name of trustees holding title to property belonging to the charity **Trustee name Dates acted if not for whole year** ## **Funds held as custodian trustees on behalf of others** Description of the assets None. held in this capacity Name and objects of the Not applicable. charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for Not applicable. safe custody and segregation of such assets from the charity’s own assets ## **Additional information (optional)** ## **Names and addresses of advisers (Optional information)** |**Type of**|**Name**|**Address**| |---|---|---| |**adviser**||| **Name of chief executive or names of senior staff members (Optional information)** ## **Exemptions from disclosure** Reason for non-disclosure of key personnel details Not applicable. ## **Other optional information** ## **2024 Future planning** - Development of a 1-day UKAOS national conference September 2024 - Planning for second AGM Feb/March 2025 to align with future conference plans - UKOF24 conference planning June 2024 - Review of the UKAOS subgroup structure - Developing and launching the concept of a UKAOS programme Management Group (PMG) to support the Board and subgroups. - Development of the first 5-year Strategy for UKAOS to be launched 2025-2030 ## **Declarations** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s) Full name(s)** Dr Hilary Williams **Position (eg Secretary,** Treasurer **Chair, etc) Date** 22/10/2024 ||**UK Acute Oncology Society (UKAOS)**

**Charity Name**|**UK Acute Oncology Society (UKAOS)**

**Charity Name**|**UK Acute Oncology Society (UKAOS)**

**Charity Name**|**1199351**
**No (if any)**|**1199351**
**No (if any)**|**CC16a**| |---|---|---|---|---|---|---| ||**For the period**
**from**|01-Jan-23
Period start date|**To**|31-Dec-23
Period end date||| |||||||| |**Section A Receipts and payments**||||||| |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**20,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**

**20,000**
**6,000**
**-**
**6,000**
**26,000**
**300**
**2,058**
**7,162 **
**900**
**-**
**-**
**-**
**-**
**-**
**10,420**
**-**
**-**
**-**
**10,420**
**15,580**
**-**
**4,494**
**20,074**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**|**Total funds**
**to the nearest £**
**20,000**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**20,000**
**6,000**
**-**
**6,000**
**26,000**
**300**
**2,058**
**7,162 **
**900**
**-**
**-**
**-**
**-**
**-**
**10,420**
**-**
**-**
**-**
**10,420**
**15,580**||**Last year**
**to the nearest £**| |Donations/grants|**20,000**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**20,000**||**3,300**| |SDECmeeting surplus|**-**|||**-**||**1,194**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| |**_Sub total_**_(Gross income for_
_AR)_|
**20,000**|||**20,000**||**4,494**| |||||||| |**Liabilities**||||||| |Fundsreceivedinerror|**6,000**||**-**
**-**
**-**|**6,000**||| ||**-**|||**-**||**-**| |**_Sub total_**|**6,000**|||**6,000**||**-**| |**_Total receipts_ **
**A3 Payments**||||||| ||||**-**|**26,000**||**4,494**| |||||||| |
Bank charges|**300**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**300**||**-**| |
Website expenses|**2,058**|||**2,058**||**-**| |
Secretariat|**7,162 **|||**7,162 **||**-**| |Accountancy|**900**|||**900**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| ||**-**|||**-**||**-**| |**_Sub total_ **|**10,420**|||**10,420**||**-**| |||||||| |**A4 Asset and investment**
**purchases (see table)**||||||| |**,**|**-**||**-**
**-**
**-**|**-**||| ||**-**|||**-**||| |**_Sub total_ **|**-**|||**-**||**-**| |**_Total payments_ **
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**||||||| ||||**-**|**10,420**||**-**| |||||||| ||**15,580**|**-**|**-**|**15,580**||**4,494**| ||**-**|**-**|**-**
**-**|**-**||**-**| ||**4,494**|**-**||**4,494**||**-**| ||**20,074**|**-**|**-**|**20,074**||**4,494**| CCXX R1 accounts (SS) 22/10/2024 1 |**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|| |---|---|---|---| |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
Bank
**Details**
Signature
**Funds received in error**|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**20,074**
**-**
**-**
**-**
**-**
**-**
**20,074**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**Unrestricted**
**6,000**
**-**
**-**
**-**
**-**
Print Name
Dr HilaryWilliams|**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||Refund made
in 2024| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| |||Dr HilaryWilliams|22/10/2024| ||||| CCXX R2 accounts (SS) 22/10/2024 2